IFNB1 and autoimmune disease: In autoimmune diseases, such as systemic lupus erythematosus and rheumatoid arthritis, SHIP1 functions as a critical negative regulator of TLR3-mediated IFN-β production through affecting the localization and activity of TBK1 (52).